About: Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $452.53 (-3.13%)
MDGL NASDAQ Madrigal Pharmaceuticals Inc
Loading watchlist status…
Madrigal Pharmaceuticals Inc share price
MDGL price activity
Last Price
$452.530
Change (24hr)
-14.64 USD (-3.13%)
Volume
84.86K
Volume (4w avg)
-
Open
$467.27
Day Range
$452.53 - $467.27
Previous Close
$467.16
Last Trade
13 Oct, 4:22 pm GMT+0
Delayed
13 Oct, 4:22 pm GMT+0
MDGL price performance
-8.85%
5D
-15.34%
1M
-22.29%
YTD
5.8%
1Y
Delayed
13 Oct, 4:22 pm GMT+0
MDGL Market Signals